Introducing MAGNA

MAGNA™ is a powerful tool designed specifically to unlock the hidden layers of information in the dynamic genome. The technology can be used to study large numbers of individual molecules of DNA, RNA, or protein.

Discover the top experts and pioneers in the field of RNA sequencing. Explore Depixus RNA Leaders to learn from the best in genomics and RNA research.

#RNASequencing #Genomics #RNAResearch #RNAExperts #DepixusRNA #Biotechnology #Innovators #GeneticScience #LifeSciences

Discover how MAGNA is revolutionizing RNA-targeted drug development and explore the future of pharmaceutical innovation. Learn more about this cutting-edge technology at Depixus.

Learn about Depixus' recent success in raising EUR 30.6 million (USD 35.4 million) in a transformative Series A financing round. Explore how this funding will drive innovation in genomics and medical research.

Discover groundbreaking technology poised to revolutionize the dynamic genomics field. Explore how Depixus is advancing research and driving innovation.

Explore how a groundbreaking technology is set to transform the field of dynamic genomics. Learn about its potential implications and applications in this insightful article.

Explore how MAGNA™ technology of depixus is driving innovation in RNA-targeted drug discovery. Discover the cutting-edge technologies and approaches that are accelerating breakthroughs in the pharmaceutical industry.

Join us at the VIB Conference as Depixus CEO presents groundbreaking insights into revolutionizing next-generation sequencing technology. Discover the future of genomics with Depixus.

Explore Depixus, pioneering advancements in genomics technology. Our innovative solutions are shaping the future of genomic research. Join us on the journey to revolutionize genomics

Explore Depixus, pioneering advancements in genomics technology. Our innovative solutions are shaping the future of genomic research. Join us on the journey to revolutionize genomics

Depixus is a new technology for measuring molecular interactions. It can be used to measure binding strength, binding structure, and binding location. It has a variety of applications, including protein-protein interactions, protein-antibody interactions, and protein-small molecule interactions.

Explore the diverse applications of Depixus technology, from protein-protein interactions to RNA-targeted drug discovery. Learn how our innovative solutions are revolutionizing molecular research.

Discover how Depixus is revolutionizing medical imaging and diagnosis. Our commitment to cutting-edge technology and healthcare excellence sets us apart. Learn more about our mission and vision.

MAGNA™ is a powerful new technology that reveals biomolecular interactions. It can be used to study the interactions of small molecule therapeutics with RNA targets in real time at the single molecule level, and to analyze individual PPIs and drug interactions at scale. MAGNA™ enables researchers to decode disease mechanisms and unlock a faster route to more effective therapies.

Explore the forefront of innovation with Depixus! Introducing our latest technology solutions that redefine possibilities. Discover how our advancements empower businesses and individuals in the digital landscape. Join us on a journey towards excellence.

MAGNA™ – Revealing the underlying biology of protein-protein interactions MAGNA™ – Revealing the underlying biology of protein-protein interactionsMAGNA™ will play a key role in advancing the rapidly emerging field of protein-protein interactions Protein–protein interactions (PPIs) play pivotal roles in the processes of life, including signal transduction, growth, and cell differentiation. There are thought to be

Explore Depixus' groundbreaking success as it secures the coveted SLAS 2024 Innovation AveNEW Award. Dive into advancements shaping the future of life sciences technology. Stay ahead with Depixus' innovative solutions and expertise.

Explore the future of RNA targeted drug discovery with Depixus! Join us at the upcoming Discovery on Target Conference as we showcase our unique single molecule technology, addressing the hit-to-lead challenge. Stay ahead in the world of pharmaceutical innovation with Depixus – transforming possibilities into breakthroughs in RNA-targeted drug development. #DrugDiscovery #RNAInnovation #DiscoveryOnTarget #Depixus

Depixus is a leading innovator in biophysics, developing cutting-edge tools like MAGNA™ to accelerate the development of new drugs. Visit our website to learn more about this revolutionary technology.

MAGNA™ is a groundbreaking technology that enables real-time, single-molecule studies of RNA and protein-protein interactions. Discover how it's transforming biomolecular research.
Breakthrough biomolecular interaction studies are now possible with MAGNA™. Dive into the details and explore its potential to unlock new scientific breakthroughs.

MAGNA™ is a groundbreaking new technology that measures interactions between biomolecules with unmatched precision. It can be used to study protein-protein, protein-antibody, protein-small molecule interactions, and more. Discover how MAGNA™ is used in RNA-targeted drug discovery and RNA binding protein research.

Depixus is a company that is developing a new technology called MAGNA™ to reveal biomolecular interactions. MAGNA™ uses magnetic force spectroscopy to decode disease mechanisms, which has the potential to lead to faster development of more effective therapies. Depixus recently won the SLAS2024 Ignite Award for its MAGNA™ technology.

Depixus introduces MAGNA™, a groundbreaking technology that utilizes magnetic force spectroscopy to examine biomolecular interactions at the single-molecule level, unlocking a new era in disease research and therapeutic development. MAGNA™ recently won the prestigious SLAS2024 Ignite Award, a testament to its revolutionary potential.

Discover how Magna from Depixus aids in the exploration of drugs targeting RNA riboswitches. Uncover the latest advancements in drug discovery technology and revolutionize your approach to RNA-targeted therapies.

This article explores MAGNA™, a groundbreaking platform that revolutionizes the study of protein-protein interactions (PPIs). PPIs are crucial in biology and disease, and MAGNA™ offers a powerful solution to overcome the limitations of current methods. Its versatility allows for in-depth analysis of diverse PPIs on a large scale, making it an invaluable tool for researchers.